Table 2 Reasons for which aortic valve replacement was excluded as therapeutic option in patients without high Euroscope who underwent treatment allocation to transcatheter valve implantations (TAVI = 55 patients), baloon aortic valvuloplasty (BAV = 13 patients), medicaltherapy (MT = 20 patients)
Reasons | Number of patients (88) | TAVI (55 patients) | BAV (13 patients) | MT (20 patients) |
|---|---|---|---|---|
Advance age (<75Â years) | 30 | 16 | 4 | 10 |
Severe chronic obstructive pulmonary disease | 14 | 10 | 2 | 2 |
Porcelain ascending aorta | 11 | 10 | 0 | 1 |
Severe chronic kidney disease | 12 | 8 | 1 | 3 |
Sclerodermia and/or severe arterial pulmonary hypertension | 5 | 3 | 2 | 0 |
Previous coronary-aortic by-pass graft | 3 | 2 | 0 | 1 |
Refuse to undergo surgery | 4 | 1 | 2 | 1 |
Hepatic cirrhosis | 3 | 3 | 0 | 0 |
Thoracic deformation | 2 | 1 | 1 | 0 |
Sever ascending aorta dilatation | 1 | 1 | 0 | 0 |
Cancer | 2 | 0 | 1 | 1 |
Previous stroke | 1 | 0 | 0 | 1 |